Data/Analytics

Boosting Physician Referrals in Today's Hypercompetitive Healthcare Environment

Boosting Physician Referrals in Today's Hypercompetitive Healthcare Environment

The focus on boosting physician referrals might appear contrary to the current obsession with patient-centric marketing.

NORD and University of Maryland partner for rare-disease research training

The National Organization for Rare Disorders and the University of Maryland will develop a training program to help caregivers and patients participate in research.

Some heartburn drugs linked to increased risk of heart attack

A data-mining analysis of patient records found a significant increase in the chance of heart attack for those taking proton-pump inhibitors.

MC10 partners with Univ. of Rochester on wearable sensor research

MC10 partners with Univ. of Rochester on wearable sensor research

The academic partnership builds on the company's 2014 collaboration with UCB on using sensors to gather biometric data about people with neurological disorders.

A Q&A with Rob Rogers, 2015 Lions Health pharma jury president

A Q&A with Rob Rogers, 2015 Lions Health pharma jury president

He spoke with MM&M about whether pharma is ready to win a Grand Prix, if regulation limits creativity in healthcare, and why wearables may spur creativity.

Five things for pharma marketers to know: Tuesday, April 14

Five things for pharma marketers to know: Tuesday, April 14

IBM takes on healthcare data; Mylan settled a lawsuit allowing it to launch generic Viagra by 2017; an FDA committee will meet today to discuss Onglyza

New guidelines recommend wait-and-see strategy for sinus infections

The American Academy of Otolaryngology said taking antibiotics for sinus infections is a slightly better treatment strategy than waiting it out.

Survey suggests doctors increasingly look for digital engagement

A new survey from Cegedim Relationship Management claims that digital tools are being underutilized and represent an opportunity to meet the demands of HCPs.

Better Rx coverage associated with outcomes lift: study

Better Rx coverage associated with outcomes lift: study

A study funded and conducted in part by the CVS Research Institute found that an expansion of prescription-drug benefits could mean better health outcomes as well as reduced spending.

Playing to Win in the Global Biosimilars Environment

Playing to Win in the Global Biosimilars Environment

"Although the United States represents almost half of the biologics market in terms of revenue and volume, biosimilars growth will be fueled by focusing on the emerging markets, by addressing non-consumption and patient inability to pay for high-priced biologics."